SAB Biotherapeutics
(NASDAQ:SABS)
$5.58
0.67[13.65%]
At close: Jan 29
$5.58
0[0.00%]
After Hours: 9:28AM EDT

GET A REPORT ON SABS SENT RIGHT TO YOUR INBOX

37.5%
Overview Rating
Unpromising asset
Technicals Analysis
66
0100
Financials Analysis
20
0100

SAB Biotherapeutics Stock (NASDAQ:SABS), Quotes and News Summary

SAB Biotherapeutics Stock (NASDAQ: SABS) stock price, news, charts, stock research, profile.
Open$4.880
Close$4.960
Volume / Avg.10.564K / 12.706K
Day Range4.710 - 5.030
52 Wk Range3.657 - 14.500
Market Cap$51.476M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
32
Short Interest
0.48%
Days to Cover1.69
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Oct 23
1
Nov 23
1
Jan
1
Strong Buy
Buy
Hold
Sell
Strong Sell
About SAB Biotherapeutics Inc
Sector
Health Care
Industry
Biotechnology
SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
SABS
ACXP

FAQ

Q

How do I buy SAB Biotherapeutics (SABS) stock?

A

You can purchase shares of SAB Biotherapeutics (NASDAQ: SABS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are SAB Biotherapeutics's (SABS) competitors?

Q

What is the target price for SAB Biotherapeutics (SABS) stock?

A

The latest price target for SAB Biotherapeutics (NASDAQ: SABS) was reported by HC Wainwright & Co. on Monday, January 8, 2024. The analyst firm set a price target for 10.00 expecting SABS to rise to within 12 months (a possible 101.61% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for SAB Biotherapeutics (SABS)?

A

The stock price for SAB Biotherapeutics (NASDAQ: SABS) is $4.96 last updated February 23, 2024 at 3:58 PM EST.

Q

Does SAB Biotherapeutics (SABS) pay a dividend?

A

There are no upcoming dividends for SAB Biotherapeutics.

Q

When is SAB Biotherapeutics (NASDAQ:SABS) reporting earnings?

A

SAB Biotherapeutics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.

Q

Is SAB Biotherapeutics (SABS) going to split?

A

There is no upcoming split for SAB Biotherapeutics.

Q

What sector and industry does SAB Biotherapeutics (SABS) operate in?

A

SAB Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch